Breast Cancer Profiling Project, Drug Sensitivity phase II: Fixed-cell GR measures of 33 breast cell lines and PDX lines to 16 small molecule perturbagens from library plate II. Dataset 1 of 2: Normalized growth rate inhibition values - Dataset (ID:20354)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Mean Normalized Growth Rate Inhibition Value | Increased Fraction Dead |
|---|---|---|---|---|
| HCC1419 | BMS-265246 | 0.01 | 0.9062 | 0.00067 |
| HCC1419 | BMS-265246 | 0.01 | 0.9279 | -0.00226 |
| HCC1419 | BMS-265246 | 0.0316227766017 | 0.7018 | 0.00673 |
| HCC1419 | BMS-265246 | 0.0316227766017 | 0.9147 | 0.00698 |
| HCC1419 | BMS-265246 | 0.0316227766017 | 0.7040 | 0.00546 |
| HCC1419 | BMS-265246 | 0.1 | 0.6836 | 0.00039 |
| HCC1419 | BMS-265246 | 0.1 | 0.6485 | -0.00158 |
| HCC1419 | BMS-265246 | 0.1 | 0.6741 | -0.00059 |
| HCC1419 | BMS-265246 | 0.316227766017 | 0.5434 | 0.00782 |
| HCC1419 | BMS-265246 | 0.316227766017 | 0.5708 | 0.01391 |
| HCC1419 | BMS-265246 | 0.316227766017 | 0.6311 | 0.01202 |
| HCC1419 | BMS-265246 | 1.0 | 0.4100 | 0.01513 |
| HCC1419 | BMS-265246 | 1.0 | 0.6154 | 0.01218 |
| HCC1419 | BMS-265246 | 1.0 | 0.4364 | 0.00347 |
| HCC1419 | BMS-265246 | 3.16227766017 | 0.3888 | 0.00729 |
| HCC1419 | BMS-265246 | 3.16227766017 | 0.5446 | 0.00368 |
| HCC1419 | BMS-265246 | 3.16227766017 | 0.2898 | 0.01381 |
| HCC1419 | BMS-265246 | 10.0 | 0.4639 | 0.01036 |
| HCC1419 | BMS-265246 | 10.0 | 0.3435 | 0.01078 |
| HCC1419 | BMS-265246 | 10.0 | 0.3465 | 0.01710 |
| HCC1419 | Ulixertinib | 0.001 | 1.0919 | -0.00589 |
| HCC1419 | Ulixertinib | 0.001 | 1.0469 | -0.00537 |
| HCC1419 | Ulixertinib | 0.001 | 1.0734 | -0.00367 |
| HCC1419 | Ulixertinib | 0.003162278 | 0.8790 | 0.00099 |
| HCC1419 | Ulixertinib | 0.003162278 | 0.9184 | 0.00072 |